Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation
Emadeldin M. Kamel, Ahmed A. Allam, Hassan A. Rudayni, Saleh Alkhedhairi, Noha A. Ahmed, Faris F. Aba Alkhayl, Al Mokhtar Lamsabhi
Springer Nature ·
2026-03-21
· DOI 10.1186/s13072-026-00663-4
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Emadeldin M. Kamel, Ahmed A. Allam, Hassan A. Rudayni, Saleh Alkhedhairi, Noha A. Ahmed, Faris F. Aba Alkhayl et al. Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation. // Epigenetics & Chromatin. – 2026. – DOI: 10.1186/s13072-026-00663-4. – URL: https://doi.org/10.1186/s13072-026-00663-4
Emadeldin M. Kamel, Ahmed A. Allam, Hassan A. Rudayni, Saleh Alkhedhairi, Noha A. Ahmed, Faris F. Aba Alkhayl, & Al Mokhtar Lamsabhi (2026). Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation. Epigenetics & Chromatin. https://doi.org/10.1186/s13072-026-00663-4
Emadeldin M. Kamel, et al. “Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation.” Epigenetics & Chromatin, 2026. doi:10.1186/s13072-026-00663-4.
@article{Kamel2026,
title = {Disrupting the ASH2L–DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation},
author = {Kamel, Emadeldin M. and Allam, Ahmed A. and Rudayni, Hassan A. and Alkhedhairi, Saleh and Ahmed, Noha A. and Alkhayl, Faris F. Aba and Lamsabhi, Al Mokhtar},
journal = {Epigenetics \& Chromatin},
year = {2026},
doi = {10.1186/s13072-026-00663-4},
url = {https://doi.org/10.1186/s13072-026-00663-4}
}